Am J Hosp Palliat Care. 2018 Jan 1:1049909118778865. doi: 10.1177/1049909118778865. [Epub ahead of print]
The Role of Palliative Medicine in Assessing Hereditary Cancer Risk.
Abusamaan MS1, Quillin JM2, Owodunni O1, Emidio O1, Kang IG3, Yu B3, Ma B3, Bailey L3, Razzak R1, Smith TJ1, Bodurtha JN1.
Hereditary cancer assessment and communication about family history risks can be critical for surviving relatives. Palliative care (PC) is often the last set of providers before death.
We replicated a prior study of the prevalence of hereditary cancer risk among patients with cancer receiving PC consultations, assessed the history in the electronic medical record (EMR), and explored patients' attitudes toward discussions about family history. This study was conducted at an academic urban hospital between June 2016 and March 2017.
The average age of the 75 adult patients with cancer was 60 years, 49 (55%) male and 49 (65%) white. A total of 19 (25%) patients had no clear documentation of family history in the EMR, sometimes because no family history was included in the admission template or an automatically imported template lacked content. In all, 24 (32%) patients had high-risk pedigrees that merited referral to genetic services. And, 48 (64%) patients thought that PC was an appropriate venue to discuss the implications of family history. The mean comfort level in addressing these questions was high.
At an academic center, 25% of patients had no family history documented in the EMR. And, 32% of pedigrees warranted referral to genetic services, which was rarely documented. There is substantial room for quality improvement for oncologists and PC specialists-often the last set of providers-to address family cancer risk before death and to increase use and ease of documenting family history in the EMR. Addressing cancer family history could enhance prevention, especially among high-risk families.
cancer; electronic health record; family history; genetic referral; genetic risk; palliative care